Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Imperial College Healthcare NHS Trust

    - PMLiVE

    Scientists uncover new drug target in fight against antimicrobial resistance

    The discovery could lead to improved treatments for bacterial infections

    - PMLiVE

    GSK’s Blenrep approved by FDA for multiple myeloma

    Approval supported by positive results from phase 3 trial

    - PMLiVE

    New study highlights global overuse of antibiotics for diverticulitis

    Researchers warn that excessive antibiotic use in diverticulitis increases risk of antimicrobial resistance and unnecessary hospital admissions

    - PMLiVE

    University of Liverpool identifies new class of antibiotic in fight against AMR

    The new antibiotic class targets two of the WHO’s ‘priority pathogens’

    - PMLiVE

    GSK and Hengrui enter multi-programme collaboration agreement worth $12bn

    The deal includes a PDE3/4 inhibitor in clinical development for COPD

    - PMLiVE

    GSK’s Blenrep combinations granted EC approval for relapsed/refractory multiple myeloma

    More than 50,000 cases of the blood cancer are diagnosed in Europe each year

    - PMLiVE

    GSK’s Blenrep combination recommended by NICE to treat multiple myeloma

    The decision means that eligible patients in England will be the first in the world to access the combination

    - PMLiVE

    GSK to acquire Boston’s liver disease candidate efimosfermin in deal worth up to $2bn

    Steatotic liver disease affects approximately 5% of the global population

    - PMLiVE

    GSK shares promising phase 3 results for linerixibat in PBC-related itch

    Pruritus is experienced by up to 90% of patients with the rare liver disease

    - PMLiVE

    UK government’s AMR study highlights importance of appropriate antibiotic use

    The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam

    - PMLiVE

    GSK’s Blenrep combinations approved by MHRA to treat multiple myeloma

    Approximately 6,500 new cases of the blood cancer are diagnosed in the UK each year

    - PMLiVE

    GSK’s five-in-one meningococcal vaccine recommended by CDC advisory committee

    Penmenvy combines the antigenic components of GSK's approved Bexsero and Menveo vaccines

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links